PharmaRadar360

PharmaRadar360

Pharmaceutical research team working in a modern facility

Pharmaceutical industry news

Fresh coverage across pharma, biotech, medtech, research, approvals, and market-moving developments.

38,389 stories, page 263 of 640

Advanced search
🌍discoverynews.google.comTier 3 · Aggregated media

Junk food ban, FSSAI licence must: A ‘to-do’ list for schools amid food safety crackdown

The Indian ExpressOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

DSCSA Can Trace a Package. It Cannot Tell Whether the Next One Will Arrive.

Pharmaceutical CommerceOriginal source
🇧🇷Regulatoryinterfarma.org.brTier 1 · Regulatory source

Interfarma apresenta Carta aos Presidenciáveis com 10 prioridades para a saúde no próximo governo

Interfarma BrazilOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Stifel reiterates Buy rating on Oculis stock, $40 target

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

How Vivek Ramaswamy’s mom manipulated Alzheimer’s data and made her son rich

Popular Information | Judd LegumOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

VERAXA Biotech (NASDAQ: VRXA) Expands Patent Portfolio to Support Next-Generation Cancer Therapy Platforms

USA TodayOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Burger King Camp, Zepto Lohgaon Among 16 Establishments Facing FDA Action in Pune Division Over Food Safety Violations

punekarnews.inOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Fierce Pharma Asia—Legend’s first profit; Taiho, Cullinan’s EGFR win; WuXi AppTec’s reprieve

Fierce PharmaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

BMS selects multi-modal biopharma manufacturing campus site

Scientist LiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech expects cash position to fund operations into Q1 2027

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Vistagen Reports Fiscal Year 2027 First Quarter Financial Results and Corporate Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ArkBio’s RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial

The Malaysian ReserveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech reports Q2 2026 loss of $7.6M, cash $7.3M; MIRACLE trial interim efficacy positive

tradingview.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Branford biotech company to cut 20% of workforce, delays new product launch

Hartford Business JournalOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Reports Second Quarter 2026 Financial

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Moleculin Biotech Reports Second Quarter 2026 Financial Results and Highlights Continued Advancement of Pivotal MIRACLE Trial

Yahoo Finance UKOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Former Legend CEO lands role at K2 Therapeutics—Chutes & Ladders

fiercebiotech.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

What is it like for a physician to work in biotech?

Medical EconomicsOriginal source
🌍Mediasaama.comTier 2 · Direct publisher

The Smarter Way to Code: A Buyer’s Guide to Medical Coding in Clinical Trials

SaamaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Lantheus Announces FDA Approval of TAUKLARIFY™ (Florquinitau F 18 Injection), an F18-Labeled Tau PET Imaging Agent for Alzheimer’s Disease

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Allarity Therapeutics Reports Second Quarter 2026 Results and Completion of the Phase 3-Ready Stenoparib Manufacturing Campaign

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Galectin Therapeutics Reports June 30, 2026 Financial Results and Provides Business Update

The Manila TimesOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Enigma Biomedical USA Announces FDA Approval of TAUKLARIFY™ (florquinitau F 18 injection) for Use in Patients Being Evaluated for Alzheimer’s Disease

businesswire.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Quantinuum, NVIDIA, and Pfizer Validate Generative Quantum AI (GenQAI) Framework for Pharmaceutical R&D

Quantum Computing ReportOriginal source
🌍discoverynews.google.comTier 2 · Trade media

FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class

STATOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Orthopaedic Implant Components

Stryker has become aware that the devices listed in the Customer Letter were manufactured with Ultra...

Health Canada Recalls and Safety AlertsOriginal source
🇨🇦Regulatoryrecalls-rappels.canada.caTier 1 · Regulatory source

Endotracheal Tube, Cuffed

The 6FR suction catheter could not pass smoothly through the 2.5mm sizes of cuffed tracheal tube. Th...

Health Canada Recalls and Safety AlertsOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Annovis Provides Corporate Updates and Second Quarter 2026 Financial Results

GlobeNewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Video: Maharashtra Food And Drug Administration Chief Tukaram Mundhe Prepares Tea For Friends

NDTV FoodOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Here Are Friday’s Top Wall Street Analyst Research Calls: Cinemark, Digital Realty, Fox Corporation, Krystal Biotech, LTC Properties, Roku, Sandisk, T-Mobile US, Wayfair, and More

24/7 Wall St.Original source
🌍discoverynews.google.comTier 3 · Aggregated media

Acurx Pharmaceuticals Q2 Results: EPS misses estimate, losses widen

scanx.tradeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Why is a drugmaker suing six sellers over a drug no one can legally buy?

Benefits and Pensions MonitorOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Video: Maharashtra Food And Drug Administration Chief Tukaram Mundhe Prepares Tea For Friends

NDTV FoodOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

From stale bread to expired rava: FDA raids reputed hospital canteen; 6 homemade healthy meals to pack in

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma Appoints Michael Halstead CEO, Completes Enrollment in Phase 3 APPROACH Study of HLP003 and Reports Q2 2026 Results

Quiver QuantitativeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

H.C. Wainwright reiterates Buy on 4D Molecular stock, $36 target

Investing.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Helus Pharma finishes Phase 3 depression trial enrollment

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Legend Biotech Gains 6% on Q2 Earnings Beat as Adjusted EPS Doubles Consensus

AOL.comOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Biotech initiatives pick up as more regions race to become hubs

BioPharma DiveOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Penny for Your Thoughts: Episode 16

Pharmaceutical CommerceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Clinilabs announces medical leadership appointments

Manufacturing ChemistOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

UKHSA updates heat health alerts across England

An amber heat-health alert is now in place across all regions in England.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

West Pharmaceutical Services (NYSE:WST) Rating Lowered to Hold at Zacks Research

MarketBeatOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Patient enrollment complete in phase 3 trial of OPGx-LCA5 for LCA5-associated inherited retinal disease

Ophthalmology Times EuropeOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Q&A: Why Is Halo Pharma Expanding Into Sterile Injectables Now?

PharmTech.comOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: HemaTrax: Lineage-resolved prediction of hematotoxicity for human-relevant drug development

CORDISOriginal source
🇪🇺Researchcordis.europa.euTier 2 · Direct publisher

CORDIS project: Conditioned CAR-T cells (cirCAR-T) for enhanced tumor immmunotherapy

CORDISOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Acurx Receives Conditional FDA Acceptance for C. difficile Drug Name

Stock TitanOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Senoia Rotary Club donates pharmaceutical disposal kiosk to city

Kiosk MarketplaceOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

CPHI Milan introduces new specialist zones

PMLiVEOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Is BioMarin Pharmaceutical (BMRN) Still Cheap As 2026 Guidance Rises And Amicus Adds Growth?

simplywall.stOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Yubo International Biotech Ltd 2Q 2026: Revenue $165.49K, Net income ($268.72K), EPS $0— 10-Q Summary

tradingview.comOriginal source
🇺🇰Regulatorygov.ukTier 1 · Regulatory source

Emergency preparedness, resilience and response: concept of operations

Building a resilient and responsive organisation ready for health security threats.

UK Health Security AgencyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Doctors and Patient Groups Flag Seven Deaths Reported to the FDA in Users of a New Prader-Willi Drug

inklOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

RBC Initiates Krystal Biotech at Outperform, With $400 Price Target

marketscreener.comOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

AI biotech company Cellular Intelligence names Arjun Raj its chief scientific officer

The Times of IndiaOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Latex-Free Gloves for Pharmaceutical Use Market to Reach Index 192 by 2035 on Biopharma Capacity Build-Out

IndexBoxOriginal source
🌍discoverynews.google.comTier 2 · Trade media

Immunology specialist Khartis Therapeutics emerges from stealth with $95m

Pharmaceutical TechnologyOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

ArkBio's RSV Antiviral Drug Ziresovir Receives FDA Approval for Phase II Clinical Trial

PR NewswireOriginal source
🌍discoverynews.google.comTier 3 · Aggregated media

Heavy R&D investment, strong policy support, and global cooperation drive rapid growth of China's innovative drug industry

Global TimesOriginal source